Detalhe da pesquisa
1.
Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
PLoS One
; 14(6): e0217881, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170245